Tag: Elysium Therapeutics

Elysium Therapeutics’ Investor Webcast Highlights “Fentanyl Rebound” as Key Challenge in Reducing Opioid Overdose Hospitalizations and Deaths

Elysium's Synthetic Opioid Overdose Prevention and Reversal (SOOPR™) technology designed specifically to combat oral fentanyl overdose LYONS, Colo., June 11, 2025 /PRNewswire/ -- Elysium Therapeutics,...

Elysium Therapeutics to Participate in the 2025 BIO International Convention to Discuss Challenge of Fentanyl Rebound and Rescue Medication Designed for Synthetic Opioids

LYONS, Colo., June 5, 2025 /PRNewswire/ -- Elysium Therapeutics, an emerging biopharmaceutical company developing treatments specifically designed to rescue and reverse overdoses caused by...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Comments

This field is for validation purposes and should be left unchanged.

HomeTagsElysium Therapeutics

TBRG Investor News: If You Have Suffered Losses in TruBridge, Inc. (NASDAQ: TBRG), You Are Encouraged to Contact The Rosen Law Firm About Your...

Bitmine Immersion Technologies Announces Initial Dividends and NYSE Listing for Series A Preferred Stock

SEEM Board Meeting and Annual Meeting of Participants and Stakeholders Scheduled on June 24

Tag: Elysium Therapeutics

Elysium Therapeutics’ Investor Webcast Highlights “Fentanyl Rebound” as Key Challenge in Reducing Opioid Overdose Hospitalizations and Deaths

Elysium Therapeutics to Participate in the 2025 BIO International Convention to Discuss Challenge of Fentanyl Rebound and Rescue Medication Designed for Synthetic Opioids

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us